Interestingly, TGF-β plays a dual role in tumor progression, acting as a negative regulator in the early stage of tumor development but inducing epithelial mesenchymal transformation (EMT) and promoting migration in the late stages of development (Wojtowicz-Praga, 2003). The gene discussed is TGFB1; the disease is neoplasm.